CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

The European Council and Parliament have reached an agreement on the European Commission’s proposal to deregulate new GMOs.

A phase 1/2 clinical trial examining the CRISPR-engineered allogeneic chimeric antigen receptor (CAR)-T candidate AVC-203 (QUADvance) has been approved by the FDA and the European Medicines Agency ...

Exagamglogene autotemcel helped children with beta thalassemia achieve transfusion independence and prevented vaso-occlusive crises among those with sickle cell disease in a pair of phase 3 ...

Cambridge-based Fulcrum Therapeutics said it will aim to launch a large clinical trial in the second half of 2026 to prove ...

Exa-cel is the first FDA-approved therapy utilizing CRISPR/Cas9, a type of gene editing technology through which patients' ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Genetic risk models and variant classification tools are refining breast cancer risk assessment by identifying high-risk ...

Venkatesan Sundaresan, a Distinguished Professor of plant biology and plant sciences, and Imtiyaz Khanday, an assistant ...

Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.

In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...

Doctors have now used a gene-edited pig liver to keep a human alive, not as a thought experiment in a lab but as a real ...